We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
CACI
CACI
$11.5B
| $11.9M | 0.03% |
55,000
+46,966
| +585% | +$11.2M |
|
502
Immatics
IMTX
$1.26B
| $11.8M | 0.03% |
750,000
-500,000
| -40% | -$6.14M |
|
503
Voya Financial
VOYA
$9B
| $11.7M | 0.03% |
250,200
-75,000
| -23% | -$3.33M |
|
|
SAFM
504
DELISTED
Sanderson Farms Inc
SAFM
| $11.7M | 0.03% |
100,706
-260,000
| -72% | -$33.4M |
|
|
IAA
505
DELISTED
IAA, Inc. Common Stock
IAA
| $11.6M | 0.03% |
+300,590
| New | +$11.2M |
|
506
Cboe Global Markets
CBOE
$30.3B
| $11.5M | 0.03% |
123,000
-2,300
| -2% | -$227K |
|
|
TPTX
507
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $11.3M | 0.03% |
175,000
+50,000
| +40% | +$2.88M |
|
508
Darden Restaurants
DRI
$23.9B
| $11.3M | 0.03% |
148,900
+9,336
| +7% | +$662K |
|
509
Coherent
COHR
$65.7B
| $11M | 0.03% |
232,095
-317,905
| -58% | -$12.6M |
|
510
Advance Auto Parts
AAP
$3.6B
| $10.9M | 0.03% |
76,800
-192,186
| -71% | -$24.4M |
|
|
GRTX
511
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $10.8M | 0.03% |
1,509,500
+200,000
| +15% | +$2.12M |
|
512
Qorvo
QRVO
$8.33B
| $10.7M | 0.03% |
97,100
-1,678
| -2% | -$166K |
|
513
ArcelorMittal
MT
$56.4B
| $10.7M | 0.03% |
+1,000,000
| New | +$10.1M |
|
|
SEI
514
Solaris Energy Infrastructure
SEI
$3.54B
| $10.5M | 0.03% |
1,421,038
-50,000
| -3% | -$327K |
|
515
Hasbro
HAS
$12.8B
| $10.5M | 0.03% |
140,472
-2,400
| -2% | -$174K |
|
516
Gartner
IT
$12.4B
| $10.5M | 0.03% |
86,600
-12,200
| -12% | -$1.41M |
|
|
ADVM
517
DELISTED
Adverum Biotechnologies
ADVM
| $10.4M | 0.03% |
50,000
-130,000
| -72% | -$23M |
|
518
Lamb Weston
LW
$7.31B
| $10.4M | 0.03% |
163,200
-2,800
| -2% | -$169K |
|
|
MXIM
519
DELISTED
Maxim Integrated Products
MXIM
| $10.3M | 0.03% |
170,400
+89,000
| +109% | +$4.96M |
|
|
NOVA
520
DELISTED
Sunnova Energy
NOVA
| $10.2M | 0.03% |
600,000
-514,782
| -46% | -$7.29M |
|
521
Astec Industries
ASTE
$1.06B
| $10.1M | 0.03% |
217,802
-782,441
| -78% | -$32.1M |
|
522
Hewlett Packard
HPE
$70.7B
| $10.1M | 0.03% |
1,036,636
-103,300
| -9% | -$1.01M |
|
523
Beam Therapeutics
BEAM
$2.83B
| $10M | 0.03% |
358,000
+26,000
| +8% | +$560K |
|
524
Old Dominion Freight Line
ODFL
$44.6B
| $9.95M | 0.03% |
117,300
-53,200
| -31% | -$4.04M |
|
525
JB Hunt Transport Services
JBHT
$25.7B
| $9.92M | 0.03% |
82,400
+3,300
| +4% | +$355K |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.